In this multi-institutions based pharmacogenetic study of NSCLC patients with platinum-based chemotherapy, we found linked non-coding variants of SLC31A1 gene, which encodes the major platinum uptake transporter, are associated with severe hematological toxicities such as thrombocytopenia and shorter overall survival. The gene discussed is SLC31A1; the disease is Thrombocytopenia.